On this page
SMARCAL1
SNF2 related chromatin remodeling annealing helicase 1
SMARCAL1 is located on the long (q) arm of chromosome 2, at band 2q35. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 2 in the library →Available at Jeen Health
Clinical tests that include this
Overview
SMARCAL1 (SNF2 related chromatin remodeling annealing helicase 1) is located on chromosome 2q35 and encodes a 954-amino acid protein belonging to the SNF2 family of chromatin remodelling enzymes. This protein plays a critical role in the cellular response to DNA replication stress by stabilising and remodelling stalled replication forks.
The gene is also known as HARP (HepA-related protein), reflecting its structural similarity to bacterial DNA helicases. Pathogenic changes in SMARCAL1 are inherited in an autosomal recessive pattern and result in Schimke immuno-osseous dysplasia, a multisystem disorder affecting skeletal development, kidney function, and immune competence. The protein's essential functions in DNA metabolism explain the severe clinical consequences when both gene copies carry damaging variants.
What the gene does
The SMARCAL1 protein coordinates the cellular response when DNA replication machinery encounters damage or other obstacles that cause replication forks to stall. When such blockages occur, SMARCAL1 binds to the affected site and uses energy from ATP hydrolysis to restructure the DNA strands, allowing repair processes to proceed and replication to resume.
Beyond its role in replication fork repair, the protein influences gene expression through two distinct mechanisms. First, it binds directly to specific DNA sequences to regulate transcription of target genes. Second, it participates in chromatin remodelling by altering how tightly DNA wraps around histone proteins. When chromatin structure is loosened, genes become more accessible for transcription; when tightened, gene expression typically decreases. This chromatin remodelling function appears particularly important during development, when precise temporal control of gene expression is required.
The protein also interacts with replication protein A (RPA2), a single-stranded DNA-binding complex that marks sites of replication stress and recruits repair factors. This interaction positions SMARCAL1 precisely where its remodelling activity is needed most urgently.
Video: Genetics 101
Chromosome location
SMARCAL1 is located on the long arm of chromosome 2 at position 2q35. The genomic locus spans a region that encodes the full-length 954-amino acid protein through multiple exons, though the precise exon structure has not been detailed in standard clinical references.
Protein structure
The SMARCAL1 protein contains several functionally distinct regions that enable its DNA repair and chromatin remodelling activities. The N-terminal region (amino acids 1-238) is largely disordered, providing flexibility for protein-protein interactions. Within this disordered segment, a short coiled coil structure (amino acids 3-34) mediates interaction with RPA2, the replication stress sensor.
Two HARP domains (HARP 1 spanning amino acids 226-303, and HARP 2 spanning amino acids 327-398) are characteristic structural features that distinguish this protein family. These domains contribute to substrate recognition and positioning.
The catalytic core comprises the Helicase ATP-binding domain (amino acids 445-600) containing the DESH box motif (amino acids 549-552), which is essential for ATP hydrolysis, and the Helicase C-terminal domain (amino acids 716-869), which completes the motor apparatus responsible for DNA strand manipulation. A nuclear localization signal (amino acids 644-661) ensures the protein reaches its site of action in the nucleus. The C-terminal region (amino acids 904-934) is also disordered, likely allowing conformational changes during the catalytic cycle.
Key variants
Pathogenic variants in SMARCAL1 typically result in loss of protein function, either by preventing production of any functional protein or by disrupting critical domains required for DNA binding, ATP hydrolysis, or chromatin remodelling. Because Schimke immuno-osseous dysplasia follows autosomal recessive inheritance, affected individuals carry damaging variants in both gene copies. The severity of clinical features can vary depending on whether variants completely abolish protein function or permit residual activity.
No pathogenic or likely-pathogenic ClinVar variants recorded yet for this gene.
Associated conditions
Pathogenic variants in SMARCAL1 cause Schimke immuno-osseous dysplasia, a rare multisystem disorder. Affected individuals typically present with disproportionate short stature due to spondyloepiphyseal dysplasia, progressive kidney disease that may advance to renal failure, and T-cell immunodeficiency leading to recurrent infections. Additional features can include distinctive facial characteristics, skin pigmentation changes, and cerebrovascular complications. The constellation of skeletal, renal, and immune abnormalities reflects the widespread importance of SMARCAL1-mediated DNA repair across multiple developing organ systems.
- Schimke immuno-osseous dysplasia Dedicated page coming soon
Inheritance pattern
Conditions caused by pathogenic SMARCAL1 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
SMARCAL1 is included on multiple NHS Genomic Medicine Service gene panels with green (high evidence) classification. It appears on the DDG2P panel for developmental disorders, the Proteinuric renal disease panel (R195), the Skeletal dysplasia panel (R104), the Primary immunodeficiency or monogenic inflammatory bowel disease panel (R15), and the Unexplained kidney failure in young people panel. This broad representation across renal, skeletal, and immunological panels reflects the multisystem nature of Schimke immuno-osseous dysplasia. The gene is also listed on the Pigmentary skin disorders panel (R236) and the COVID-19 research panel.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
How is SMARCAL1-related Schimke immuno-osseous dysplasia inherited?
Schimke immuno-osseous dysplasia follows autosomal recessive inheritance, meaning an affected individual has inherited a pathogenic variant from each parent. Parents who each carry one variant typically show no symptoms but have a 25% chance with each pregnancy of having an affected child.
What does the SMARCAL1 protein do in cells?
The SMARCAL1 protein rescues stalled DNA replication forks by remodelling DNA structure at damage sites, allowing repair processes to occur and replication to resume. It also regulates gene expression by altering chromatin structure, influencing how accessible DNA is for transcription during development and cellular stress responses.
Why does SMARCAL1 loss affect multiple organ systems?
Because SMARCAL1 maintains genomic stability during DNA replication, its loss disrupts cell division across all tissues. Rapidly dividing cells in developing bone, kidney, and immune system are particularly vulnerable to replication stress, explaining why Schimke dysplasia affects skeletal growth, renal function, and T-cell immunity.